KESTRA MEDICAL TECHNOLOGIES, LTD.
KMTS · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Revenue | $22,565 | $19,371 | $17,233 | $15,090 |
| % Growth | 16.5% | 12.4% | 14.2% | – |
| Cost of Goods Sold | $11,141 | $10,520 | $9,600 | $8,543 |
| Gross Profit | $11,424 | $8,851 | $7,633 | $6,547 |
| % Margin | 50.6% | 45.7% | 44.3% | 43.4% |
| R&D Expenses | $4,878 | $4,001 | $5,386 | $3,353 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $38,301 | $33,728 | $50,459 | $23,795 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $43,179 | $37,729 | $55,845 | $27,148 |
| Operating Income | -$31,755 | -$28,878 | -$48,212 | -$20,601 |
| % Margin | -140.7% | -149.1% | -279.8% | -136.5% |
| Other Income/Exp. Net | -$996 | $3,085 | -$2,797 | -$1,140 |
| Pre-Tax Income | -$32,751 | -$25,793 | -$51,009 | -$21,741 |
| Tax Expense | $34 | $33 | $102 | $18 |
| Net Income | -$32,785 | -$25,826 | -$52,053 | -$21,509 |
| % Margin | -145.3% | -133.3% | -302.1% | -142.5% |
| EPS | -0.64 | -0.5 | -2.21 | -0.5 |
| % Growth | -28% | 77.4% | -342% | – |
| EPS Diluted | -0.64 | -0.5 | -2.21 | -0.5 |
| Weighted Avg Shares Out | 51,376 | 51,305 | 49,534 | 49,534 |
| Weighted Avg Shares Out Dil | 51,376 | 51,305 | 49,534 | 49,534 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,796 | $2,167 | $1,656 | $628 |
| Interest Expense | $1,901 | $1,912 | $1,760 | $1,783 |
| Depreciation & Amortization | $2,373 | $2,028 | $1,836 | $1,888 |
| EBITDA | -$28,477 | -$21,853 | -$47,413 | -$18,070 |
| % Margin | -126.2% | -112.8% | -275.1% | -119.7% |